Related references
Note: Only part of the references are listed.Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-β gene
Satoko Shibata et al.
JOURNAL OF IMMUNOLOGY (2006)
Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors
M Tanii et al.
CIRCULATION RESEARCH (2006)
Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis
MA Björndahl et al.
CANCER RESEARCH (2005)
Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, pigment epithelium-derived factor, in human atherosclerotic plaques
H Baba et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas
Y Shikada et al.
CANCER RESEARCH (2005)
Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries
T Nakano et al.
HUMAN PATHOLOGY (2005)
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis
RH Cao et al.
CANCER CELL (2004)
Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis
TV Petrova et al.
NATURE MEDICINE (2004)
Essential role of PDGFRα-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo -: Role of PDGFRα during angiogenesis
N Tsutsumi et al.
CIRCULATION RESEARCH (2004)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Molecular characterization of lymphatic endothelial cells
S Podgrabinska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs
M Onimaru et al.
CIRCULATION RESEARCH (2002)
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea
H Kubo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia
AN Witmer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Angiogenic gene therapy for experimental critical limb ischemia - Acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
I Masaki et al.
CIRCULATION RESEARCH (2002)
Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats
A Yamashita et al.
JOURNAL OF IMMUNOLOGY (2002)
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
T Veikkola et al.
EMBO JOURNAL (2001)
Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards
SE Epstein et al.
CARDIOVASCULAR RESEARCH (2001)
A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression
HO Li et al.
JOURNAL OF VIROLOGY (2000)
Efficient gene transfer to airway epithelium using recombinant Sendai virus
Y Yonemitsu et al.
NATURE BIOTECHNOLOGY (2000)
Share Paper
